Ait-Mohand S - Search Results

1

Antibody-Based PET Imaging of Misfolded Superoxide Dismutase 1 in an Amyotrophic Lateral Sclerosis Mouse Model.

Rousseau JA, Maier M, Ait-Mohand S, Dumulon-Perreault V, Sarrhini O, Tremblay S, Rousseau E, Salzmann M, Guérin B. Rousseau JA, et al. Among authors: ait mohand s. J Nucl Med. 2025 Jan 3;66(1):130-135. doi: 10.2967/jnumed.124.268343. J Nucl Med. 2025. PMID: 39667814 Free PMC article.

2

⁶⁸Ga-DOTATATE Prepared from Cyclotron-Produced ⁶⁸Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer Patients.

Tremblay S, Beaudoin JF, Bélissant Benesty O, Ait-Mohand S, Dumulon-Perreault V, Rousseau É, Turcotte ÉE, Guérin B. Tremblay S, et al. Among authors: ait mohand s. J Nucl Med. 2023 Feb;64(2):232-238. doi: 10.2967/jnumed.121.263768. Epub 2022 Jul 29. J Nucl Med. 2023. PMID: 35906092 Free PMC article.

3

Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [⁶⁴Cu]-DOTHA₂-PEG-RM26.

Mansour N, Paquette M, Ait-Mohand S, Dumulon-Perreault V, Guérin B. Mansour N, et al. Nucl Med Biol. 2018 Jan;56:31-38. doi: 10.1016/j.nucmedbio.2017.10.006. Epub 2017 Oct 23. Nucl Med Biol. 2018. PMID: 29154145

4

[⁶⁸Ga]Ga-4HMSA a promising new PET tracer for imaging inflammation.

Kahn Ali S, Ait-Mohand S, Dumulon-Perreault V, Guérin B. Kahn Ali S, et al. Among authors: ait mohand s. EJNMMI Res. 2021 Oct 30;11(1):114. doi: 10.1186/s13550-021-00856-w. EJNMMI Res. 2021. PMID: 34718888 Free PMC article.

5

⁶⁴Cu-DOTHA₂-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window.

Milot MC, Benesty OB, Dumulon-Perreault V, Ait-Mohand S, Richard PO, Rousseau É, Guérin B. Milot MC, et al. Among authors: ait mohand s. Pharmaceuticals (Basel). 2022 Aug 13;15(8):996. doi: 10.3390/ph15080996. Pharmaceuticals (Basel). 2022. PMID: 36015144 Free PMC article.

6

Total solid-phase synthesis of NOTA-functionalized peptides for PET imaging.

Guérin B, Ait-Mohand S, Tremblay MC, Dumulon-Perreault V, Fournier P, Bénard F. Guérin B, et al. Org Lett. 2010 Jan 15;12(2):280-3. doi: 10.1021/ol902601x. Org Lett. 2010. PMID: 20014826

7

Comparative study of 64Cu/NOTA-[D-Tyr6,βAla11,Thi13,Nle14]BBN(6-14) monomer and dimers for prostate cancer PET imaging.

Fournier P, Dumulon-Perreault V, Ait-Mohand S, Langlois R, Bénard F, Lecomte R, Guérin B. Fournier P, et al. EJNMMI Res. 2012 Feb 14;2:8. doi: 10.1186/2191-219X-2-8. EJNMMI Res. 2012. PMID: 22333272 Free PMC article.

8

PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.

Couture F, Levesque C, Dumulon-Perreault V, Ait-Mohand S, D'Anjou F, Day R, Guérin B. Couture F, et al. Neoplasia. 2014 Aug;16(8):634-43. doi: 10.1016/j.neo.2014.07.010. Neoplasia. 2014. PMID: 25220591 Free PMC article.

9

Promising Performance of 4HMS, a New Zirconium-89 Octadendate Chelator.

Alnahwi AH, Ait-Mohand S, Dumulon-Perreault V, Dory YL, Guérin B. Alnahwi AH, et al. Among authors: ait mohand s. ACS Omega. 2020 May 5;5(19):10731-10739. doi: 10.1021/acsomega.0c00207. eCollection 2020 May 19. ACS Omega. 2020. PMID: 32455192 Free PMC article.

10

Theranostic ⁶⁴Cu-DOTHA₂-PSMA allows low toxicity radioligand therapy in mice prostate cancer model.

Milot MC, Bélissant-Benesty O, Dumulon-Perreault V, Ait-Mohand S, Geha S, Richard PO, Rousseau É, Guérin B. Milot MC, et al. Among authors: ait mohand s. Front Oncol. 2023 Jan 18;13:1073491. doi: 10.3389/fonc.2023.1073491. eCollection 2023. Front Oncol. 2023. PMID: 36741017 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters